{"result": {"id": "chatcmpl-580", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "Sunitinib is a tyrosine kinase inhibitor used in both research and clinical settings. It works by inhibiting the growth of specific cancer cells through blocking the activity of certain genes involved in cell growth, particularly those with mutations (CNV) associated with various types of cancers.  This drug's effectiveness stems from its ability to block angiogenesis, the formation of new blood vessels. Sunitinib is classified as an antiangiogenic drug and specifically targets angiogenesis. Clinical trials are currently underway to evaluate its potential in treating gastroesophageal malignancies. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743288821, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 110, "prompt_tokens": 278, "total_tokens": 388, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"SUNITINIB\"\nDescription List: [\"Sunitinib is a drug used in both research and clinical settings. It is a tyrosine kinase inhibitor that targets specific cancer cells by inhibiting their growth.  Sunitinib's effectiveness stems from its ability to block the activity of certain genes involved in cell growth, particularly those with mutations (CNV) associated with various types of cancers. \\n\", \"The **SUNITINIB** is an antiangiogenic drug, meaning it inhibits the formation of new blood vessels. It is also a drug that specifically targets angiogenesis, the process of forming new blood vessels.  Clinical trials are currently being conducted to evaluate its effectiveness in treating gastroesophageal malignancies. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_2747a3c87b17da947531016bb47332cf192dc7bf9b709719f98ff5bf29407a20_v2"}